» Articles » PMID: 34819053

Pretic-I Was a Safe and Effective Artificial Cervical Disc Prosthesis--a Retrospective and Comparative Study with 5-year Follow-up

Overview
Publisher Biomed Central
Specialties Orthopedics
Physiology
Date 2021 Nov 25
PMID 34819053
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The newly designed cervical disc prosthesis, Pretic-I, had been finished its limited clinical use for over 5 years. At a short-term follow-up of 2 years, we obtained satisfactory clinical results. The long-term clinical efficacy and safety of Pretic-I will now be analyzed.

Methods: Peri-operative parameters included intra-operative blood loss, operation time, off-bed time. Clinical parameters included visual analogue scale (VAS) for arm and neck, neck disability index (NDI), and Japanese Orthopaedic Association (JOA) score. Radiological parameters included C2-7 Cobb angle, Shell angle, and the range of motion (ROM) of C2-7, functional segment unit (FSU), and adjacent FSU. The CDA-related complications included adjacent segment degeneration (ASDeg), adjacent segment disease (ASDis), heterotopic ossification (HO), prosthesis subsidence, prosthesis displacement, and dysphagia.

Results: A total 64 patients from two independent centers received a single-level CDA with Discover (n = 32) and Pretic-I (n = 32), and all of patients finished a 5-year follow-up. There're no significant differences between two groups in peri-operative parameters. The clinical parameters improved greatly in Pretic-I group (p<0.0001), and there's no statistical difference from Discover group. Furthermore, Pretic-I could slightly improve the cervical curvature (15.08 ± 11.75 to 18.00 ± 10.61, p = 0.3079) and perfectly maintain the Shell angle (3.03 ± 3.68 to 2.23 ± 4.10, p = 0.1988), cervical ROM (52.48 ± 14.31 to 53.30 ± 11.71, p = 0.8062) and FSU ROM (12.20 ± 4.52 to 10.73 ± 4.45, p = 0.2002). The incidence of high-grade HO (Grade III-IV) at the final follow-up was significantly lower in Pretic-I group than in Discover group (12.50% vs. 34.38%, p = 0.0389, Statistical Power = 95.36%). The incidences of other CDA-related complications in Pretic-I group were also well-accepted, comparable to the Discover group, without significant differences.

Conclusion: CDA with Pretic-I demonstrated a well-accepted and sustained clinical outcome, with a significantly lower incidence of high-grade HO. This newly designed prosthesis is expected to become an alternative choice for cervical disc prosthesis in the future.

References
1.
Hilibrand A, Robbins M . Adjacent segment degeneration and adjacent segment disease: the consequences of spinal fusion?. Spine J. 2004; 4(6 Suppl):190S-194S. DOI: 10.1016/j.spinee.2004.07.007. View

2.
Mehren C, Suchomel P, Grochulla F, Barsa P, Sourkova P, Hradil J . Heterotopic ossification in total cervical artificial disc replacement. Spine (Phila Pa 1976). 2006; 31(24):2802-6. DOI: 10.1097/01.brs.0000245852.70594.d5. View

3.
Pandey P, Pawar I, Gupta J, Verma R . Comparison of Outcomes of Single-Level Anterior Cervical Discectomy With Fusion and Single-Level Artificial Cervical Disc Replacement for Single-Level Cervical Degenerative Disc Disease. Spine (Phila Pa 1976). 2016; 42(1):E41-E49. DOI: 10.1097/BRS.0000000000001696. View

4.
Liu H, Deng Y, Liu Z, Wang B, Ding C, Hong Y . [Early effectiveness of cervical disc replacement by using Pretic-I]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018; 31(5):513-518. PMC: 8498256. DOI: 10.7507/1002-1892.201612146. View

5.
Suchomel P, Jurak L, Benes 3rd V, Brabec R, Bradac O, Elgawhary S . Clinical results and development of heterotopic ossification in total cervical disc replacement during a 4-year follow-up. Eur Spine J. 2009; 19(2):307-15. PMC: 2899807. DOI: 10.1007/s00586-009-1259-3. View